Artisan Partners
ISEE

Artisan Partners’s IVERIC bio, Inc. Common Stock ISEE Stock Holding History

Artisan Partners’s Portfolio ISEE Stock Details ISEE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-311,121
Closed -$7.57M – 348
2023
Q1 		$7.57M Buy
+311,121
New +$6.81M 0.01% 291

Other funds holding ISEE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Avoro Capital Advisors
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
UBS O'Connor
UBS O'Connor Chicago, Illinois $3.76B AUM 62.41% 1-Year Est. Return
BCM
Beryl Capital Management Redondo Beach, California $111M AUM 205.39% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
TAL
TIG Advisors LLC New York $2.26B AUM 81.38% 1-Year Est. Return

Artisan Partners's ISEE Position: Q2 2023 in Review

Artisan Partners sold out of IVERIC bio, Inc. Common Stock (ISEE) in Q2 2023, closing a stake of 311,121 shares — an estimated $7.57M sold.

Artisan Partners first reported a position in ISEE in Q1 2023 and held it in 1 quarter. The position peaked at $7.57M in Q1 2023. 255 funds tracked by Wall St. Rank hold ISEE as of Q2 2023.

  • Artisan Partners reported no remaining IVERIC bio, Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
  • Artisan Partners sold 311,121 IVERIC bio, Inc. Common Stock shares in Q2 2023, an estimated $7.57M.
  • Artisan Partners first reported a position in IVERIC bio, Inc. Common Stock in Q1 2023 and held it in 1 quarter.
  • Artisan Partners's IVERIC bio, Inc. Common Stock position peaked at $7.57M in Q1 2023.
  • 255 funds tracked by Wall St. Rank held IVERIC bio, Inc. Common Stock as of Q2 2023.

Based on Artisan Partners's 13F filing for Q2 2023, filed 10 Aug 2023.